TNF-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in tumor cell lines, suggesting its great potential in cancer therapy. Many components in TRAIL-mediated signaling pathway have been identified, but how they interact with each other to determine the network dynamics and final apoptosis remains elusive. Here we constructed a mathematical model of this pathway, which integrated current available information from related experimental literatures, to make a systematic and quantitative description of the cellular responses to TRAIL stimulation. By applying sensitivity analysis, we identified the key components and reactions that have the highest impact on the network dynamics, and then analyzed the regulatory role of several key players in this pathway. To elucidate the function of TRAIL decoy receptors, we compared the competitive ligand binding hypothesis versus the pre-ligand binding hypothesis. Our results show that the pre-ligand binding hypothesis is more suitable for explaining the fact that over-expression of decoy receptors can inhibit apoptosis potently. These results, together with our investigation on other downstream proteins and feedback loops in this pathway, provide insights into the molecular mechanisms of the TRAILmediated apoptosis pathway.
Introduction
TNF-related apoptosis inducing ligand (TRAIL) is a member of the TNF family which selectively induces cancer cell death by apoptosis [1, 2] . This process is mediated by transmembrane TRAIL receptors and through a pathway that finally activates caspase-3, the effector caspase for programmed cell death. Figure 1 is a schematic representation of the TRAIL-mediated caspase-3 activation. TRAIL-mediated apoptosis involves pathways type I and II [3, 4] , both leading to the activation of the apical/activator caspase, caspase-8 (or caspase-10), and consequently the activation of the effector caspase, caspase-3. In both pathways, TRAIL binds to receptors on plasma membrane and forms a trimmer, which then recruits Fas-associated death domain, FADD [5] . FADD promotes the formation of death-inducing signaling complex, DISC, which then activates caspase-8. In type I pathway, activated caspase-8 directly cleaves and activates caspase-3. Although in type II pathway, caspase-8 cleaves Bid into tBid to initiate the oligomerization of Bax, and leads to the release of cytochrome C and Smac from mitochondrion. Consuming ATP, cytochrome C binds to caspase-9 and Apaf-1 to form apoptosome, which finally cleaves and activates caspase-3/7 [2, 6] . Bcl-2, FLICE-inhibitory protein (FLIP), and X-linked inhibitor of apoptosis protein (XIAP) are important regulators in this TRAIL-mediated apoptosis pathway. FLIP inhibits caspase-8 activation via competitive binding to DISC [7, 8] . Bcl-2 is shown to interact with both tBid and Bax to inhibit type II pathway [9, 10] . XIAP blocks caspase-3 and apoptosome [11] but could be inhibited by Smac [12] . In addition, Mcl-1 and Bim are assumed to be another two important regulatory factors in TRAIL-mediated apoptosis. Previous data show that Mcl-1 sequestrates Bim on mitochondrion membrane, although TRAIL-activated caspase-8 and caspase-3 cleave Mcl-1 to produce free Bim that mediates the release of cytochrome C from mitochondrion in a Bax-dependent manner [13, 14] .
In TRAIL-mediated apoptosis pathway, the role of the TRAIL receptors is of particular interest (Fig. 1, red dash arrows). TRAIL binds to five distinct TNF receptor (TNFR)-like receptors, TR1 (TRAIL-R1/DR4), TR2 (TRAIL-R2/DR5), TR3 (TRAIL-R3/DcR1), TR4 (TRAIL-R4/DcR2), and the soluble receptor osteoprotegerin [1, 15] . TR1 and TR2 can recruit FADD and induce cell death [15, 16] . In contrast, TR3 and TR4 are decoy receptors that might somehow inhibit apoptosis [17, 18] with controversial mechanisms. Previous studies have developed two possible models explaining how these receptors regulate TRAIL signaling. The first model suggests the competitive binding of TR2 and TR4 towards TRAIL [1, 17, 18] , although the second one suggests a ligand-independent association between TR2 and TR4 [19] . To date, the molecular mechanisms by which TR3 and TR4 confer resistance to TRAIL-induced apoptosis remain a controversial topic. Initial binding experiments suggested that TRAIL binding affinities to TRAIL agonistic and antagonistic receptors were similar, but subsequent studies demonstrated that TR3 or TR4 affinity to TRAIL was lower than that of TR1 or TR2 [20] . The different results obtained in previous studies may come from distinct experimental contexts. For example, the groups used different cells in their experiments, and the cells have distinct genetic background, which may lead to the discrepancy of results.
Therefore, although many molecular components in this pathway have been identified, a systematic understanding of the network dynamics of the TRAIL pathway is still in need. One of the major purposes of our systems modeling is to verify biological hypothesis in dynamic and quantitative context, and uncover the molecular mechanism of TRAIL signaling pathway. Hua et al. [10] , Fusenegger et al. [21] , and Benetele et al. [22] have done brilliant work on the mathematical modeling of apoptosis. However, the TRAIL-induced apoptosis is not included in their studies. Albeck et al. [24] described a computational model of TRAIL-induced apoptosis, which focused on the XIAP and proteasome-dependent degradation of effector caspases. In this article, we generated a mathematical model of the TRAIL-induced apoptosis pathway. This model can not only accurately represent known experimental data but also serve as a useful tool to develop and test hypotheses. Using this model, we predicted the response of cell when treated with TRAIL of different concentrations, and analyzed the parameter sensitivity of the model which indicates the key regulatory factor of this pathway. In addition, we explored the mechanism through which TRAIL decoy receptors inhibit apoptosis, and further studied an intrinsic feedback loop of this pathway [23] from a perspective of systems biology.
Materials and Methods

Model description
Our work was based on the previous experimental research findings and information concerning TRAIL-mediated apoptosis signaling pathway. The model of TRAIL apoptosis pathway is similar to Fas apoptosis pathway described in Hua's work [10] except that the ligand and receptors are different. First we translated the TRAIL pathway into a series of biochemical reactions ( Fig. 2 and Supplementary data). Three classes of kinetics were involved.
Mass-action equation for molecular combination and decomposition:
where k f and k r are the rates of the forward and reverse reaction. Michaelis-Menten function (actually be split into two Mass-Action reactions) for enzymatic reactions:
where E is enzyme, S is substrate, ES is the complex, P is the product, K 1 , K 2 , and K 3 are the rates of the reactions. Equations for substance release from mitochondrion:
where A* is the A released from the mitochondrion, B is the catalyzer, k f is the rate of the reaction.
On the basis of the reaction scenario, we established systematic models described by ordinary differential equations (ODEs).
The equation for Mass -Action equation:
The equation for Michaelis-Menten function: The equation for substance release from mitochondrion:
Matlab, COPASI [25] , SBtoolbox [26] [27] [28] , and PottersWheel (http://www.potterswheel.de/) were used to calculate the model states and solve the ODE models. The programs developed by COPASI have been uploaded to the Supplementary data (http://www.abbs.info/42-02/ 09287supplementary.htm).
Parameters
Differential equation simulation requires the accurate knowledge ( parameters) about each step of the biochemical reactions. We inferred each parameter value of our model based on previous experimental reports on various apoptosis pathways (TRAIL [19, 29] , TNF-a [30] , and Fas pathway [10] ). For the parameters that lack literature records, we adjusted their value manually to achieve consistence with other parameters. Table 1 shows the initial concentration of the components. Table 2 indicates the kinetic parameters (reaction rate constants).
Sensitivity analysis
Sensitivity represents the change of output resulting from a tiny perturbation of the initiate state or the reaction parameters. In our study, the sensitivity analysis is performed [10] to estimate the impact of every parameter on the response in this pathway. If the perturbation Dk in the parameter set induces an overall state change Dy, then the sensitivity is defined as Dy/Dk. In this study, Dy is the change of period when half amount of the full length caspase-3 was cleaved. COPASI [25] , SBtoolbox [26] [27] [28] , and PottersWheel (http:// www.potterswheel.de/) are used to calculate the relative sensitivity of different parameters in the pathway.
Cell culture, flow cytometry, and western blot HeLa cells were grown in DMEM supplemented with 10% FBS (Hyclone, Logan, USA) and 1% penicillinstreptomycin at 378C under 5% CO 2 . Cells were transfected with Lipofectamine (Invitrogen, Carlsbad, USA) according to the manufacturer's instruction. The plasmids used for transfection are constructed based on pcDNA4-myc vector by subcloning the DR5 and DcR1 genes into the multiple clone sites. For flow cytometric analysis, cultured cells were removed by trypsinization, fixed in 1% paraformaldehyde at room temperature, and permeabilized in 0.1% digitonin. Cells were then incubated with appropriate primary antibodies in PBS containing 1% FBS and 0.05% digitonin at 48C. All the primary antibodies used are purchased from Sigma-Aldrich (St. Louis, USA), and diluted according to the manufacturer's recommendation. After washed with PBS, cells were stained by FITC-conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, USA) for 30 min in the same buffer of primary antibodies. Totally, 10,000 cells were analyzed by flow cytometry. For western blot, the cells were lysed in lysis buffer (10 mM HEPES, pH 7.4, 2 mM EGTA, 0.5% NP-40, and protease inhibitors). Equivalent samples (20 mg protein) were subjected to SDS -PAGE (0.1% SDS) and then transferred onto nitrocellulose membranes. Membranes were probed with the indicated primary antibodies followed by appropriate HRP-conjugated secondary antibodies (KPL, Gaithersburg, USA). Immunoreactive bands were visualized with a chemiluminescence kit (Pierce, Rockford, USA).
Results
Model simulation and sensitivity analysis of TRAIL-mediated apoptosis pathway Since the caspase-8 and caspase-3 are regarded as the most important signal transducers in the process of apoptosis, here we used the concentration of TRAIL as external input, and the activation of caspase-8 and caspase-3 as output to assess the response of this model to signals. Our primary model included the fundamental elements and interactions of apoptosis pathways, which were identical in many apoptosis pathways. Thus, the simulation result revealed curvilinear trend of caspase-8, and caspase-3 cleavage (Fig. 3) , which is similar to the previous reported Fas signaling model [10] .
In order to validate our simulation, we compared our caspase-8 activation curve with the experimental results reported by Sprick et al. [40] . Their data showed that in Jurkak cells, the full length caspase-8 level constitutively decreases in response to TRAIL stimulation, with about 40% remained after 8 h [ Fig. 3(C) ]. Similarly, we compared the caspase-3 activation with the previous experimental results [41] . The experimental data showed that the full length caspase-3 level had little change after TRAIL treatment for 1 h, but had more than 50% decrease after TRAIL treatment for 3 h, which is consistent with our simulation. Taken these together, our model agrees well with the experimental analysis of TRAIL pathway.
Next we identified the key components and reactions in the TRAIL signal transduction system. Unlike death receptors (TR1/TR2), the expressions of decoy receptors are not widespread. Some tissues in human do not express TR4 [42] . So we did not add TR4 to the model in the sensitivity analysis. Figure 4(A) showed the relative sensitivity of the kinetic parameters, and the sensitivity of the initial values is shown in Fig. 4(B) . These results indicated that the reactions with the most sensitive kinetic parameters were TRAIL-receptor interactions, the caspase-8 and caspase-3 activation, the Smac/IAP inhibition, and the activation of Bid. These key reactions included the most important regulatory factors of this pathway: signal reception by the TRAIL receptors, the caspases activation, the mitochondrial regulation, and the Bid activation. It is also noticeable that some of the initial concentrations, such as cytochrome C and ATP, have little impact on the apoptosis. This might be because that the basic level of these molecules exceeds the demand of TRAIL transduction, given the fact that they could be also involved in other biological processes.
Model simulation at the receptor level
Previous studies have provided two hypotheses about how the receptors regulate TRAIL signaling. The first hypothesis is the competitive binding of TR2 and TR4 with TRAIL, although the second one suggests a ligandindependent association between TR2 and TR4 ( pre-ligand binding). To study which model is more appropriate, we started with experimentally investigating the function of TR2 and TR4 in TRAIL-mediated apoptosis. Both of our flow cytometry and caspase-8 activation data showed that TR2 (DR5) positively whereas TR3 (DcR1) negatively regulated TRAIL-mediated apoptosis (Fig. 5) . Next, in our computational model, we simulated the time scale of caspase-8 and caspase-3 activation under different mechanisms of TRAIL receptor interaction. The cleavage of the full-length caspase-8 reduced dramatically under the receptor competition hypothesis but not under the preligand binding hypothesis [ Fig. 6(A) ]. These results suggest a higher efficiency of signaling inhibition by the pre-ligand binding mechanism. However, the activation of caspase-3 changes little under either hypothesis [ Fig. 6(B) ]. , and pcDNA4-myc-DcR1, respectively. After 20 h, cells were subjected to flow cytometric analysis. The histograms show protein levels of endogenous/exogenous DR5 or DcR1. In left panel, the black dashed line indicates endogenous DcR1, the dashed blue line indicates endogenous DR5, the green line indicates exogenous DcR1, the red line indicates exogenous DR5, and the gray line indicates staining control. In right panel, the navy blue column indicates endogenous DcR1, the purple column indicates endogenous DR5, the yellow column indicates exogenous DcR1, and the light blue column indicates exogenous DR5. (B) HeLa cells transfected with recombinant plasmids were treated with 200 ng/ml TRAIL for 12 h. Flow cytometric analysis of apoptosis is performed using binding of Annexin V and Propidium iodide. In right panel, the navy blue column is DcR1, the purple column is control, and the yellow column is DR5. (C) Activation of caspase-8. HeLa cells were treated as (B), then collected and subjected to western blotting with anti-caspase-8 antibody. Expression of exogenous DR5 and DcR1 were detected using antibody specific for c-Myc tag. b-actin was used as a loading control. The graph in the right panel indicates the pro-caspase-8/b-actin ratio under different conditions. In right panel, the navy blue column is DcR1, the purple column is control, and the yellow column is DR5.
Afterwards, we asked whether the TRAIL concentration is critical for the caspase-3 activation. We performed timecourse simulations with 10 and 1% of the initial TRAIL concentration. The receptor-binding hypotheses mentioned above were tested, respectively [ Fig. 6(C,D) ]. The results show that with the decrease of TRAIL concentration, there is only a small decrease of caspase-3 activation comparing with [ Fig. 6(B) ]. Also there is little difference between two receptor-binding hypotheses. Therefore, it seems that the TRAIL concentration within this range does not decide the caspase-3 activation. This is inconsistent with experimental observation that saturated TRAIL level does not further promote cell apoptosis.
From our experimental results, we observed that increase of decoy receptor (TR3) can inhibit apoptosis. Then we asked under which receptor-binding hypothesis we could simulate the experimental observation best. Our computational results showed that under the pre-ligand binding hypothesis, but not the competitive binding hypothesis, the increase of TR3 significantly inhibited caspase-3 activation [comparing Fig. 6(F,G) with Fig. 6(E) ]. Altogether, our modeling and simulation show that when the expression level of the decoy receptors is much higher than the death receptors, they can negatively regulate the TRAIL-mediated apoptosis pathway, by means of their preligand binding to the death receptors.
Model simulation at the downstream levels
In addition to performing simulation at the receptor level, we also performed simulation at distinct downstream levels. First, to better illustrate the dynamic features of caspase activation, we compared the caspase-8 and caspase-3 activation levels at different TRAIL concentrations within 8 h using three-dimensional analysis. The results show that there is only a slight decrease of caspase-8 activation with TRAIL treatment [ Fig. 7(A) ], but a more significant decrease of caspase-3 activation with TRAIL treatment [ Fig. 7(B) ]. Considering that caspase-3 is the downstream substrate of caspase-8, this data may indicate that the death signal undergoes an amplification process during its transmission from caspase-8 to caspase-3, which sensitizes cell to TRAIL stimulus.
After analyzing the signal transducer, caspases, we further analyzed another signal transducer, tBid, and some signal inhibitors, including Mcl-1 [13, 14] , Bcl-2, and XIAP. We simulated their changes of concentration on the time scale. Interestingly, we found that the decrease of XIAP and Mcl-1 levels happened at early stage of TRAIL treatment, and this was accompanied by the rapid increase of activated caspase-3 and tBid (Fig. 8) . This 'none-or-all' molecular mechanism might improve the responsiveness of cell to death signal by means of a prompt exhaustion of the anti-apoptotic factors [39, 43] .
The feedback loops exist extensively in various transduction pathways, and play important roles especially in the dynamic behaviors such as oscillation, amplification, and bistability. In the following part, we analyzed a possible feedback loop in apoptosis pathway. Mcl-1 can inhibit caspase-3 through interacting with Bim, whereas caspase-3 can also inhibit the function of Mcl-1 through breaking the Mcl-Bim interaction, so here a positive feedback loop is formed. We added this positive feedback loop to our model systems, and tested whether it would influence our simulation result. However, inconsistent with the previous suggestion from experimental works [23] , we found no significant impact of the feedback loop on the rate or intensity of the caspase-3 activation (Fig. 9) . Thus, we conjectured that although the feedback loop might enhance signaling magnification to some extent, but when considering the signal system as a whole, it is unable to play a decisive role in the total signal output.
These simulations, together with our simulations at the receptor level, reflect the overall complexity of TRAIL-mediated apoptosis pathway. In the experimental studies, people could only work on a small part isolated from the entire system, and the results they get might simply represent the features of an individual component. It is difficult for them to uncover biological processes in a panoramic way unless systematic modeling is introduced. Therefore, our system-based analysis here can improve people's understanding of the apoptosis pathway.
Discussion
Apoptosis is a vital biological process under tight controls implemented by many molecules. Disruption of these molecules often leads to aberrant apoptosis and many pathological processes including cancers. The TRAIL-mediated apoptosis signaling, with its unique selectivity to cancer cells, is of widespread concern. Most components in TRAIL apoptotic signal pathway have been studied through a variety of experimental approaches, which aims to study the characteristics of an individual molecule in a specific type of cell and under a constrained environment. However, with these scattered, isolated and sometimes even conflicting data, we still could not see how these seemingly independent components interact with each other and function as a whole. Thus, in order to summarize and reorganize existing knowledge, and also to establish a comprehensive framework for further analysis, we established a mathematical model of TRAIL pathway which could help us in these aspects. We collected and collated existing knowledge related to the TRAIL pathway and established a computational model using ODEs on the basis of reaction kinetics. Our systematic analysis helps us to understand the regulatory mechanism of TRAIL-mediated apoptosis. In this model, we could verify the experimental observation in a logical and integrated context. More importantly, so far it is the only way that we could study the entire operation and the dynamic characteristics of the signal transduction in response to the stimuli, so as to enhance understanding of the complex biological signaling systems [10, 32, 44] , and guide the biologist in experiment design as well as theory development. As a next step, it will be useful to include more detailed elements of TRAIL pathway excluded in the current study. Moreover, the proposed model based on a system-theoretic approach can be extended and is applicable to other signaling pathways in the similar manner.
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